ARTICLE | Clinical News
FDA accepts Valeant's tretinoin lotion NDA for acne
January 19, 2018 6:23 AM UTC
Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) said FDA accepted for a review an NDA for Altreno tretinoin 0.05% (IDP-121) to treat acne. The PDUFA date is Aug. 27...
BCIQ Company Profiles